Charles River Laboratories | CRL - Cash And Equivalent

Stock Price
171.23
Daily Change
1.43 0.84%
Monthly
7.21%
Yearly
48.79%
Q2 Forecast
166.17

Charles River Laboratories reported $213.77M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Agilent USD 1.76B 31M Dec/2025
Align Technology USD 1B 103.43M Sep/2025
Bio-Rad Laboratories USD 529.8M 134M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Cigna USD 7.68B 1.65B Dec/2025
Concord Medical Services Hldg CNY 243.38M 85.1M Jun/2023
CVS Health USD 8.45B 645M Dec/2025
Danaher USD 5.7B 1.09B Mar/2026
Dentsply International USD 326M 37M Dec/2025
Elevance Health USD 9.66B 166M Mar/2026
Galapagos EUR 87.87M 23.41M Dec/2025
Humana USD 4.2B 1.19B Dec/2025
Illumina USD 1.42B 368M Dec/2025
Incyte USD 3.58B 650.78M Dec/2025
Intrexon USD 9.34M 1.77M Jun/2024
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratory Of America USD 532.3M 65.8M Dec/2025
Lonza CHF 719M 188M Dec/2025
McKesson USD 2.96B 1.05B Dec/2025
Merck EUR 2.25B 1.08B Sep/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Quest Diagnostics USD 393M 27M Mar/2026
Revvity USD 919.86M 11.53M Dec/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
United Therapeutics USD 1.56B 217M Dec/2025
UnitedHealth USD 31.23B 3.11B Mar/2026
Veradigm USD 492.6M 7.57M Sep/2022
Waters USD 587.83M 128.71M Dec/2025
West Pharmaceutical Services USD 521.4M 269.9M Mar/2026